IDEAYA Biosciences Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 32.45, 121.28, 220, 519.55, 1034.98 ], "ebit_estimate": [ -424.16, -381.68, -297.89, -115.52, 215.72 ], "ebitda_estimate": [ -433.01, -393.17, -294.36, null, null ], "net_income_estimate": [ -386.55, -372.03, -311.59, -156.43, 241.96 ], "per_share_eps_estimate": [ -4.29, -3.73, -3.34, -1.08, 2 ], "eps_nri_estimate": [ -4.29, -3.88, -3.12, -1.58, 2 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 7.6, 7.38, 4.5, null, null ], "pretax_income_estimate": [ -385.56, -354.82, -310.78, -88.11, 272.59 ], "operating_cash_flow_per_share_estimate": [ -4.08, -3.84, -3.22, null, null ], "roa_estimate": [ -41.2, -44.1, -47.8, null, null ], "roe_estimate": [ -43.25, -50.29, -46.5, null, null ], "gross_margin_estimate": [ 99.2, 91.4, 92.54, 91.87, 90.03 ], "operating_cash_flow_estimate": [ -361.45, -340.61, -285.17, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 18.51 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -31.47, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -34.8, "future_pretax_income_estimate_growth": -34.09, "future_book_value_per_share_estimate_growth": -25.07, "future_roa_estimate_growth": -60.13, "future_roe_estimate_growth": -56.79, "future_gross_margin_estimate_growth": -3.1, "future_operating_cash_flow_per_share_estimate_growth": -50.89 }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 5.19, 5.16, 13.2, 13.11, 17.28, 45.6, 42.14, null ], "ebit_estimate": [ -104.6, -105.69, -107.2, -104.73, -105.37, -85.87, -94.9, null ], "ebitda_estimate": [ -110.8, -96.74, -117.19, null, null, null, null, null ], "net_income_estimate": [ -94.99, -96.23, -98.07, -95.67, -95.73, -76.7, -85.4, null ], "per_share_eps_estimate": [ -1.07, -1.05, -1.07, -1.09, -1.06, -0.85, -0.86, 0.35 ], "eps_nri_estimate": [ -1.07, -1.05, -1.07, -1.09, -1.06, -0.85, -0.86, 0.34 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 9.5, 8.43, 7.34, null, null, null, null, null ], "pretax_income_estimate": [ -95.31, -95.87, -97.86, -95.67, -95.73, -76.7, -85.53, null ], "operating_cash_flow_per_share_estimate": [ -1.17, -1.18, -1.2, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -46.48, -46.15, -51.68, null, null, null, null, null ], "gross_margin_estimate": [ 100, 95, 95, 100, 100, 91, 86, null ], "operating_cash_flow_estimate": [ -103.78, -104.67, -106.44, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -31.47, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -34.8, "future_pretax_income_estimate_growth": -34.09, "future_book_value_per_share_estimate_growth": -25.07, "future_roa_estimate_growth": -60.13, "future_roe_estimate_growth": -56.79, "future_gross_margin_estimate_growth": -3.1, "future_operating_cash_flow_per_share_estimate_growth": -50.89 }